Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase 1/2 4Phase NA 2Phase 3 1

Status

Recruiting 3Unknown 1

Sponsor Class

INDUSTRY 91OTHER 40NIH 11OTHER_GOV 4NETWORK 2FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4Genitourinary 1Gastrointestinal 1

Conditions

Stomach Neoplasms 8Breast Neoplasms 8Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Small Cell Lung Carcinoma 4Neoplasms 4Multiple Myeloma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Parasomnias 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Melanoma 2Lymphoma 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Head and Neck Neoplasms 2HIV Infections 2Fatigue 2Erectile Dysfunction 2Carcinoma, Hepatocellular 2Vitamin D Deficiency 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Untreated Advanced Non-small Cell Lung Cancer 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1

Interventions

surufatinib 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER_GOV × Small Cell Lung Carcinoma × Clear all
NCT03093688 2025-07-02

Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor

Shanghai Public Health Clinical Center

Phase 1/2 Recruiting
40 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT06527898 2024-09-19

Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer

Anhui Provincial Hospital

Phase 1/2 Recruiting
45 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06479473 2024-08-09

Radiotherapy to All Residual Lesions After Chemoimmunotherapy

Anhui Provincial Hospital

Phase 1/2 Recruiting
150 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05882630 2023-05-31

Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer

Fujian Cancer Hospital

Phase 1/2 Unknown
39 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡